What is Nexgel Inc (NXGL) stock price today?

Nexgel Inc (NXGL) currently trades at $0.59 per share. The stock has a market capitalization of $5.14M and a P/E ratio of —x.

Is NXGL stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Nexgel Inc has a Smart Value Score of 28/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Nexgel Inc's revenue and earnings?

Nexgel Inc has trailing twelve-month (TTM) revenue of $11.42M with profit margins of -26.30%. Earnings per share (EPS) is $-0.38.

Is NXGL stock overvalued or undervalued?

Based on our DCF model, Nexgel Inc's intrinsic value is $6.04, representing a margin of safety of 76.82%. The stock currently trades at a P/E of —x.

NXGL

Nexgel Inc

NASDAQ: NXGL · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$0.59

-1.63% today

Updated 2026-04-30

Market cap

$5.14M

P/E ratio

—

P/S ratio

0.45x

EPS (TTM)

$-0.38

Dividend yield

—

52W range

$1 – $3

Volume

0.4M

Market cap

$5.14M

P/E ratio

—

P/S ratio

0.45x

EPS (TTM)

$-0.38

Dividend yield

—

52W range

$1 – $3

Volume

0.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$2.00

+238.87%

12-Month target

—

Intrinsic (DCF)

$6.04

Margin of safety

+76.82%

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $253000.00 — positive

+ 76.82% below intrinsic value

Risks

- Thin margins at -26.30%

- Revenue declining -8.10% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$2.05M	$4.09M	$8.69M	$11.42M	$11.42M
Net income	$-4.75M	$-3.16M	$-3.28M	$-3.00M	$-970000.00
EPS	—	—	—	—	$-0.38
Free cash flow	$-3.09M	$-3.93M	$-4.31M	$-1.38M	$253000.00
Profit margin	-231.74%	-77.21%	-37.76%	-26.27%	-26.30%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
NXGL	$5.14M	28	5.3	2.0	6.7	5.0	+76.82%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Nexgel Inc trades at $0.59. Our Smart Value Score of 28/100 indicates the stock is weak. TTM revenue stands at $11.42M. with profit margins at -26.30%. Our DCF model estimates intrinsic value at $6.04.

Frequently asked questions

What is Nexgel Inc's stock price?

Nexgel Inc (NXGL) trades at $0.59.

Is Nexgel Inc overvalued?

Smart Value Score 28/100 (Grade F, Strong Sell). DCF value $6.04.

What is the price target of Nexgel Inc (NXGL)?

The analyst target price is $2.00, representing +238.9% upside from the current price of $0.59.

What is the intrinsic value of Nexgel Inc (NXGL)?

Based on our DCF model, intrinsic value is $6.04, a +76.8% margin of safety versus $0.59.

What is Nexgel Inc's revenue?

TTM revenue is $11.42M.

Company info

SectorHEALTHCARE

IndustryMEDICAL INSTRUMENTS & SUPPLIES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.45x

ROE-52.70%

Beta0.85

50D MA$0.85

200D MA$1.79

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

NXGL vs LLY →NXGL vs JNJ →NXGL vs ABBV →Stock screener →